SKI Market

Indian Indices

Sensex

85,041.45 -367.25
( -0.43%)

Global Indices

Nasdaq

48,752.17 288.75
(0.60%)

Dow Jones

6,952.35 21.56
(0.31%)

Hang Seng

50,641.54 233.75
(0.46%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.57 -0.04
(-0.05%)

EUR-INR

105.52 0.34
(0.32%)

GBP-INR

120.86 0.52
(0.43%)

JPY-INR

0.57 0.00
(0.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Kilitch Drugs (India) Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524500

INE729D01010

180.7312064

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KILITCH

18.97

602.48

EPS(TTM)

Face Value()

Div & Yield %

18.17

Back

Longview Tea Company standalone net profit declines 56.90% in the June 2025 quarter

Aug 12,2025

Net profit of Longview Tea Company declined 56.90% to Rs 0.25 crore in the quarter ended June 2025 as against Rs 0.58 crore during the previous quarter ended June 2024. There were no Sales reported in the quarter ended June 2025 as against Rs 1.02 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	0	1.02	-100
OPM %	0	-9.80	-
PBDT	0.63	0.80	-21
PBT	0.62	0.79	-22
NP	0.25	0.58	-57

85,041.45 -367.25 ( -0.43%)

48,752.17 288.75 (0.60%)

6,952.35 21.56 (0.31%)

50,641.54 233.75 (0.46%)

9,870.68 -18.54 (-0.19%)

89.57 -0.04 (-0.05%)

105.52 0.34 (0.32%)

120.86 0.52 (0.43%)

0.57 0.00 (0.60%)